Generic Product News

Published Online: Tuesday, August 6, 2013
Follow Pharmacy_Times:

Methylphenidate Hydrochloride Tablets

Marketed by: Caraco Pharmaceutical Laboratories
Compare to: Ritalin (Novartis)
Indication: Caraco Pharmaceutical Laboratories, a division of Sun Pharmaceutical Industries Limited, has released methylphenidate hydrochloride, a generic equivalent to Novartis’ Ritalin. It is indicated for the treatment of attention deficit disorder symptoms, including moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. It is contraindicated in patients with marked anxiety, tension, and agitation, in patients with motor tics or a family history or diagnosis of Tourette’s syndrome, and in patients with glaucoma.
Dosage Form: Tablets: 5, 10, and 20 mg
For More Information:

My Way LevonorgestreL Tablets, 1.5 Mg
Marketed by: GAVIS Pharmaceuticals
Compare to: Plan B (Teva Pharmaceuticals)
Indication: My Way levonorgestrel tablets, 1.5 mg, was launched by GAVIS Pharmaceuticals. My Way levonorgestrel tablets are a generic equivalent to Teva’s Plan B, and are indicated to prevent pregnancy after known or suspected contraceptive failure or unprotected intercourse. Tablets should be taken orally within 72 hours of unprotected intercourse or contraceptive failure. Tablets are more effective if taken earlier within the 72-hour window.
Dosage Form: Tablets: 1.5 mg
For More Information:

Diphenhydramine Hydrochloride Injection, USP
Marketed by: BD Rx Inc
Indication: BD has released Diphenhydramine Hydrochloride Injection, USP, to launch BD Simplist, its line of prefilled generic injectable medications. It is indicated for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated.
Dosage Form: Injection: 50 mg/mL
For More Information:

Calcitriol Soft Gel Capsules
Marketed by: Heritage Pharmaceuticals Inc
Compare to: Rocaltrol (Hoffmann-La Roche)
Indication: Heritage Pharmaceuticals Inc announces the availability of calcitriol soft gel capsules, an AB-rated generic equivalent to Hoffmann-La Roche’s synthetic vitamin D product Rocaltrol. It is indicated for the treatment of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure who are not yet on dialysis. It is also indicated for the management of hypocalcemia in patients who are undergoing dialysis.
Dosage Form: Capsules: 0.25 and 0.5 mcg
For More Information:

Related Articles
The FDA today approved Novartis’ secukinumab (Cosentyx), an interleukin-17A antagonist, for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
Community pharmacists are most concerned about below-cost reimbursement for certain generic drugs as well as exclusionary Medicare drug plans according to a survey conducted by the National Community Pharmacists Association that asked its members to help identify the organization’s 2015 priorities.
Novartis announced that it has submitted New Drug Applications to the FDA for QVA149 and NVA237, investigational drugs for the long-term maintenance treatment of chronic obstructive pulmonary disease, following positive results from phase 3 trials of the drugs.
Mylan and Teva have separately announced the US launches of their respective valsartan tablets, the generic version of Novartis’ antihypertensive agent, Diovan.
Latest Issues
  • photo
    Pharmacy Times
    Health-System Edition
    Directions in Pharmacy
    OTC Guide
    Generic Supplements
  • photo
    Pharmacy Careers
    Specialty Pharmacy Times